JOHNSON & JOHNSON

Official Publications Johnson & Johnson Berne S.E.

Equities

000943981

US4781601046

End-of-day quote Berne S.E. Other stock markets 18:00:00 2024-06-30 EDT			5-day change	1st Jan Change
131.5 ^CHF	-0.07%		-1.01%	+0.09%

07-01	New semester, new state of mind
06-28	Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial	MT

Official Publications

SEC Filing 10Q-2	22-07-28	CO
Slide show half-year results	22-07-18	CO
1st-half-year results	22-07-18	CO
SEC Filing 8K	22-07-18	CO
Dividends	22-07-17	CO
SEC Filing 10Q-1	22-04-28	CO
SEC Filing 8K	22-04-27	CO
Slide show Q1	22-04-18	CO
SEC Filing 8K	22-04-18	CO
1st quarter results	22-04-18	CO
SEC Filing 8K	22-01-05	CO

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm

Protect and grow your investments with the help of our experts

Securing my Investments

fermer